Request demo

In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv

  • Citation
SHARE
Molecules | 2023

Maurya, S., Jain, A., Rehman, M.T., Hakamy, A., et al.; In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules 2023, 28(4), 1652. https://doi.org/10.3390/molecules28041652

View publication

Related Science Resources

Finding Spirocyclic and Strongly sp3 Cores as Scaffold and R-group Replacements
We show how Spark™ can focus searches on sp3 rich fragments to achieve compound designs with improved properties
Evidence-based successful example of a structure-based approach for the prediction of designer fentanyl-like molecules
Emerging Trends in Drugs, Addictions, and Health | 2024 Giuseppe Floresta, Valeria Catalani, Vincenzo Abbate,Evidence-based successful example...
Integrated computational approaches for designing potent pyrimidine-based CDK9 inhibitors: 3D-QSAR, docking, and molecular dynamics simulations
Computational Biology and Chemistry | 2024 Iffat Habib, Tahir Ali Chohan, Talha Ali Chohan, Fakhra Batool, Umair Khurshid, Anjum Khursheed,...

Subscribe & Don't Miss Out

Receive our newsletter to be among the first to hear about product releases, case studies, opinion articles, events and more.
Subscribe